Hypophysitis is inflammation of the pituitary gland, a pea-sized structure at the base of the brain that orchestrates hormone production throughout the body. Once considered extremely rare, hypophysitis is now recognized far more often, partly because MRI imaging has improved and partly because a whole new category of cases has emerged as a side effect of cancer immunotherapy drugs. The condition can mimic a pituitary tumor on scans, disrupt multiple hormone systems at once, and in some cases resolve on its own without aggressive treatment.
What Hypophysitis Actually Is
The pituitary gland has two main lobes. The anterior lobe produces hormones that control the thyroid, adrenal glands, growth, and reproductive organs. The posterior lobe stores and releases hormones that regulate water balance and, during childbirth, uterine contractions. A thin stalk connects the gland to the brain’s hypothalamus. Hypophysitis can inflame any of these parts, either individually or together, and the pattern of inflammation determines which hormones are affected.
The inflammation itself is driven by immune cells infiltrating pituitary tissue, damaging hormone-producing cells in the process. In the most common form, lymphocytic hypophysitis, the infiltrate is dominated by T cells (especially a subtype called CD4 cells), along with plasma cells, macrophages, and other immune cells.1PubMed Central. Progress in investigating pituitary stalk lesions: A review The gland swells, the stalk thickens, and normal hormone-secreting tissue gets crowded out or destroyed. If the immune attack is severe enough or goes on long enough, some hormone deficiencies become permanent.
Types and Causes
Hypophysitis is classified both by the pattern of immune cells found in the tissue and by its underlying cause. Histologically, five types have been described: lymphocytic, granulomatous, xanthogranulomatous, xanthomatous, and necrotizing.2PubMed. Spectrum of different types of hypophysitis: a clinicopathologic study of hypophysitis in 31 cases In practice, lymphocytic hypophysitis is by far the most common primary form. Granulomatous hypophysitis, where the tissue shows clusters of immune cells forming granulomas with multinucleated giant cells, is the next most recognized.3PubMed Central. Granulomatous hypophysitis: rare disease with challenging diagnosis
These histological types map onto three broad causal categories:
- Primary autoimmune: The immune system attacks the pituitary directly, without an identifiable external trigger. Lymphocytic hypophysitis falls here, along with IgG4-related hypophysitis, a distinct entity where IgG4-positive plasma cells infiltrate the gland and often other organs as well.
- Secondary: The pituitary inflammation results from a systemic disease such as sarcoidosis, histiocytosis, tuberculosis, or Sjögren syndrome.4The Journal of Clinical Endocrinology & Metabolism. Deciphering the Presentation and Etiologies of Hypophysitis Highlights the Need for Repeated Systematical Investigation The pituitary is caught in crossfire rather than being the primary target.
- Drug-induced: Immune checkpoint inhibitors used in cancer treatment, particularly ipilimumab, can trigger pituitary inflammation as a side effect.5European Journal of Endocrinology. Hypophysitis: diagnosis and treatment
The Pregnancy Connection
Lymphocytic hypophysitis was first recognized in women during late pregnancy or shortly after delivery, and for decades it was considered primarily a peripartum disease. Research has shown that autoantibodies from patients with peripartum lymphocytic hypophysitis target an enzyme called enolase, which is expressed in both pituitary tissue and the placenta. That shared autoantigen provides a plausible explanation for why pregnancy can trigger or unmask the condition.6PubMed. Pituitary autoantibodies in lymphocytic hypophysitis target both gamma- and alpha-Enolase – a link with pregnancy?
That said, the picture has shifted over the years. A systematic review and meta-analysis found that while roughly three-quarters of lymphocytic hypophysitis patients are women, most cases, about 80%, are not associated with pregnancy.7The Journal of Clinical Endocrinology & Metabolism. Outcomes of Initial Management Strategies in Patients With Autoimmune Lymphocytic Hypophysitis: A Systematic Review and Meta-analysis So while the pregnancy link is real and well-established mechanistically, the classic teaching that lymphocytic hypophysitis is “a disease of pregnant women” overstates it considerably. Men get it too, and most women who develop it are not pregnant at the time.
IgG4-Related Hypophysitis
IgG4-related hypophysitis deserves its own discussion because it looks and behaves differently from the lymphocytic form. It tends to affect men more than women, with a reported male-to-female ratio of about 1.5 to 1, and the average age at diagnosis is in the mid-fifties.8PubMed Central. Clinical Characteristics of 76 Patients with IgG4-Related Hypophysitis: A Systematic Literature Review It is part of a broader condition called IgG4-related disease, which can simultaneously affect the pancreas, kidneys, lungs, salivary glands, and other organs. In a review of 76 cases, the median number of organs involved was 1.5, with the lung, retroperitoneum, and kidney among the most common extra-pituitary sites.9PubMed Central. Clinical Characteristics of 76 Patients with IgG4-Related Hypophysitis: A Systematic Literature Review
Hormonal damage in IgG4-related hypophysitis is often extensive. In that same review, over half of patients had panhypopituitarism, meaning all anterior and posterior pituitary axes were affected. Gonadotropin deficiency was the most frequent individual deficit, followed closely by ACTH (cortisol) and TSH (thyroid) deficiency.10PubMed Central. Clinical Characteristics of 76 Patients with IgG4-Related Hypophysitis: A Systematic Literature Review Diagnosis can be made using a set of clinical criteria that combine pituitary MRI findings, serum IgG4 levels, evidence of IgG4 disease in other organs, histopathology, and response to steroid treatment.11PubMed Central. IgG4-related hypophysitis: a retrospective cohort study Notably, roughly a quarter of patients have normal serum IgG4 levels despite biopsy-confirmed disease, so a normal blood test does not rule it out.12PubMed Central. Clinical Characteristics of 76 Patients with IgG4-Related Hypophysitis: A Systematic Literature Review
Checkpoint Inhibitor-Induced Hypophysitis
This is the category that has driven most of the recent clinical interest. Ipilimumab, a drug used against melanoma and other cancers, blocks a protein called CTLA-4 that normally keeps immune responses in check. Removing that brake helps the immune system attack tumors but also unleashes it against healthy tissue, including the pituitary. The incidence of hypophysitis after ipilimumab treatment ranges from roughly 2% at lower doses to as high as 17% at higher doses.13PubMed Central. Managing Ipilimumab-Induced Hypophysitis: Challenges and Current Therapeutic Strategies
The mechanism appears to involve a two-stage immune attack. First, the drug binds to CTLA-4 expressed on pituitary cells, triggering complement activation and an acute inflammatory reaction. Later, a slower wave of lymphocyte-driven damage follows.14PubMed Central. Managing Ipilimumab-Induced Hypophysitis: Challenges and Current Therapeutic Strategies The result is often sudden-onset headache, fatigue, and hormone deficiencies developing weeks to months into cancer treatment. Unlike primary autoimmune hypophysitis, checkpoint inhibitor-induced cases are relatively easy to suspect when the clinical context is clear, and they have become common enough that oncologists screen for them routinely.
Symptoms
Hypophysitis produces two broad categories of symptoms. The first comes from the mass effect of the swollen gland pressing on surrounding structures. The pituitary sits in a small bony pocket (the sella turcica), so even modest swelling can cause persistent headaches. If the gland expands upward enough to compress the optic nerves crossing overhead, vision can deteriorate, typically starting with peripheral vision loss.15PubMed. Hypophysitis
The second category involves hormonal disruption, and this is where the condition does its most lasting damage. The pattern of hormone loss varies depending on which part of the pituitary is inflamed. When the posterior lobe or stalk is affected, diabetes insipidus is common, causing excessive thirst and enormous volumes of dilute urine. In one series of 22 primary hypophysitis patients, over 80% had posterior pituitary involvement leading to diabetes insipidus, while the most frequently affected anterior hormones were cortisol and thyroid hormone, each deficient in about a third of patients.16Endocrinology and Metabolism. Clinical Characteristics, Management, and Outcome of 22 Cases of Primary Hypophysitis Cortisol deficiency is the most dangerous of these because it can cause life-threatening adrenal crisis during illness or stress.
How Hypophysitis Is Diagnosed
Diagnosis is tricky because hypophysitis looks a lot like a pituitary tumor on standard imaging. An enlarged pituitary with a mass-like appearance resembles a macroadenoma in roughly half of primary hypophysitis cases.17The Journal of Clinical Endocrinology & Metabolism. Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease – Section: What Are the Radiological Features of Hypophysitis? In a surgical review, about 40% of patients who underwent surgery for suspected hypophysitis were initially thought to have an adenoma.18PubMed. Redefining the role of surgery in hypophysitis: Our experience, and a literature review
Certain MRI features tip the balance toward hypophysitis rather than tumor. A meta-analysis of lymphocytic hypophysitis imaging found that pituitary contrast enhancement (about 63% of cases), symmetric gland enlargement (60%), pituitary stalk thickening (58%), and loss of the normal bright signal from the posterior pituitary (50%) are the most common findings.19Archives of Medical Science. Clinical presentation and magnetic resonance imaging characteristics of lymphocytic hypophysitis: a systematic review with meta-analysis A so-called “dural tail” sign, where the lining of the brain next to the gland lights up on contrast MRI, appears in roughly 9% of cases and can also help distinguish hypophysitis from adenoma.20Archives of Medical Science. Clinical presentation and magnetic resonance imaging characteristics of lymphocytic hypophysitis: a systematic review with meta-analysis
Several scoring systems have been developed to avoid unnecessary surgery. One radiologic score combining eight features including stalk size, gland symmetry, signal intensity, and posterior bright spot presence correctly classified 97% of patients as having either hypophysitis or adenoma.21PubMed Central. A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively A simpler clinical scoring system that awards points for diabetes insipidus, stalk thickening, absence of cavernous sinus invasion, and absence of visual symptoms identified hypophysitis with 100% sensitivity when the score was 3 or above.22PubMed. Preoperative differentiation of hypophysitis and pituitary adenomas using a novel clinicoradiologic scoring system
Blood antibodies against pituitary tissue (antipituitary antibodies) seem like they should be useful for diagnosis, and researchers have tried to make them work for decades. In practice, the results remain inconsistent. The sensitivity and specificity of these antibodies for autoimmune hypophysitis are too low to use them reliably as a standalone diagnostic tool.23PubMed. Diagnosis and classification of autoimmune hypophysitis Specialized immunofluorescence techniques using baboon pituitary tissue have shown some promise in identifying which pituitary cell types are being targeted, potentially predicting future hormone deficits, but these methods are confined to research settings and are far from routine clinical use.24PubMed. Use of serum pituitary antibodies to improve the diagnosis of hypophysitis
Treatment With Glucocorticoids
High-dose steroids (glucocorticoids) are the standard first treatment for primary hypophysitis. They suppress the immune attack and can shrink the swollen gland, sometimes dramatically. But the response is inconsistent. Radiologic improvement, meaning the gland gets smaller on MRI, occurs in roughly three-quarters of treated patients. Hormonal recovery is harder to achieve.25The Journal of Clinical Endocrinology & Metabolism. Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease – Section: How Should Hypophysitis Be Treated?
How steroids are given matters. A systematic review found that intravenous steroids led to significantly better visual field recovery (over 90%) compared to oral steroids (about 55%). Cortisol-axis recovery was also roughly twice as likely with intravenous dosing. Longer treatment courses, beyond about six and a half weeks, were associated with better recovery of both cortisol and thyroid function.26Endocrine Connections. Glucocorticoid therapy as first-line treatment in primary hypophysitis: a systematic review and individual patient data meta-analysis The catch is that relapse is common. In one series, nearly all steroid-treated patients had a good initial response, but relapse or treatment failure followed in about 40%.27The Journal of Clinical Endocrinology & Metabolism. Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease – Section: How Should Hypophysitis Be Treated?
When Steroids Are Not Enough
For patients whose hypophysitis relapses after initial steroid treatment or persists despite it, a growing toolkit of non-steroid immunosuppressants is available, though the evidence base is still built on case series and small studies rather than randomized trials. A systematic review identified azathioprine as the most commonly used second-line drug, followed by mycophenolate, rituximab, and methotrexate. Overall, these drugs achieved clinical improvement in about 91% of patients and radiologic shrinkage in about 72%. Rituximab stood out with 100% radiologic response across the eight patients who received it, compared to roughly 37% for azathioprine.28PubMed. Non-Glucocorticoid Immunosuppressive Therapy in Post-Glucocorticoid Persistent or Recurrent Primary Autoimmune Hypophysitis: A Systematic Review
Hormonal recovery, though, remained modest even with these drugs, at about 26% overall.29PubMed. Non-Glucocorticoid Immunosuppressive Therapy in Post-Glucocorticoid Persistent or Recurrent Primary Autoimmune Hypophysitis: A Systematic Review That gap between radiologic and hormonal improvement is a recurring theme across all treatments for hypophysitis: you can get the swelling down, but once hormone-producing cells are destroyed, they rarely come back. In one reported case, a patient with recurrent autoimmune hypophysitis who had relapsed on azathioprine achieved sustained remission lasting more than four years after rituximab treatment.30PubMed Central. Recurrent autoimmune hypophysitis treated with rituximab: a case report These are encouraging results, but the total number of patients studied remains very small, and side effects including liver inflammation and low white blood cell counts occurred in about 20% of patients receiving non-steroid immunosuppressants.31PubMed. Non-Glucocorticoid Immunosuppressive Therapy in Post-Glucocorticoid Persistent or Recurrent Primary Autoimmune Hypophysitis: A Systematic Review
The Role of Surgery
Surgery for hypophysitis occupies a shrinking niche. A literature review covering 289 operated patients found that the two main reasons for operating were misdiagnosis as a pituitary adenoma (about 40% of cases) and severe visual impairment (another 40%). Visual improvement after surgery was excellent, seen in 80-90% of patients. But endocrine outcomes were poor: about 20% of patients developed new hormone deficiencies after surgery, and only 13% showed hormonal improvement.32PubMed. Redefining the role of surgery in hypophysitis: Our experience, and a literature review
The current view is that surgery should be reserved for patients with visual loss that does not respond to steroids and for situations where the diagnosis genuinely cannot be established any other way. As diagnostic scoring systems improve and clinicians become more adept at recognizing hypophysitis on imaging, the number of patients going under the knife for what turns out not to be a tumor should continue to fall.
Long-Term Hormone Replacement and Spontaneous Recovery
Regardless of whether hypophysitis is treated with steroids, immunosuppressants, or surgery, many patients end up needing lifelong hormone replacement. In one cohort, 82% of patients treated with surgery or high-dose steroids still required continuous hormone replacement at follow-up.33Endocrinology and Metabolism. Clinical Characteristics, Management, and Outcome of 22 Cases of Primary Hypophysitis Hydrocortisone and thyroid hormone are the replacements most commonly needed. The cortisol axis rarely recovers, but gonadal and thyroid function sometimes do, which is why these should be reassessed periodically rather than assumed to be permanently gone.34The Journal of Clinical Endocrinology & Metabolism. Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease – Section: How Should Hypophysitis Be Treated?
Perhaps surprisingly, doing nothing is sometimes a reasonable approach. In a German cohort of patients with primary hypophysitis managed by observation alone, about 46% showed radiologic improvement over time, and about a third had hormonal recovery, mainly in the vasopressin (water-balance) and cortisol axes.35The Journal of Clinical Endocrinology & Metabolism. Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease – Section: How Should Hypophysitis Be Treated? This does not mean treatment is unnecessary, but it does mean that the decision to start high-dose steroids should weigh their side effects against the possibility that the condition might burn itself out. For patients with mild symptoms and no visual threat, watchful waiting with hormone replacement as needed is a legitimate strategy.
Why Hypophysitis Can Still Mimic a Tumor
Even with improved awareness and scoring systems, some cases of hypophysitis remain genuinely indistinguishable from pituitary tumors before surgery. One reason is that lymphocytic hypophysitis can occasionally present with completely normal pituitary hormone levels, mimicking a non-functioning adenoma, the kind of pituitary tumor that produces no hormonal excess.36PubMed Central. Unique case of lymphocytic hypophysitis with normal pituitary hormone serology mimicking a non-functioning pituitary adenoma Without the typical clues of hormone deficiency or diabetes insipidus, and with an MRI showing a pituitary mass, clinicians may reasonably conclude they are dealing with a tumor. The only definitive way to tell them apart in such cases is tissue biopsy, which usually means surgery. Scoring systems help avoid this scenario in many patients, but not all.
There is also the issue of overlap: some patients have both hypophysitis and a pituitary adenoma simultaneously, or develop one after the other. And secondary causes like sarcoidosis or histiocytosis can produce pituitary masses that look identical to primary hypophysitis on MRI. This is why guidelines emphasize systematic investigation for underlying diseases in anyone diagnosed with pituitary inflammation, rather than assuming the autoimmune label fits every case.37The Journal of Clinical Endocrinology & Metabolism. Deciphering the Presentation and Etiologies of Hypophysitis Highlights the Need for Repeated Systematical Investigation